Home / Health / Cancer Gene Pioneer Dr. Fraumeni Dies at 93
Cancer Gene Pioneer Dr. Fraumeni Dies at 93
10 Jul
Summary
- He co-discovered Li-Fraumeni syndrome, a hereditary cancer predisposition.
- Dr. Fraumeni founded the field of molecular epidemiology.
- His work identified environmental and lifestyle cancer risks.
Dr. Joseph F. Fraumeni Jr., a pivotal figure in cancer research and the founder of molecular epidemiology, died on June 22 at the age of 93. He is renowned for his collaboration with Frederick P. Li in identifying Li-Fraumeni syndrome, one of the first recognized hereditary disorders significantly increasing the risk of developing various cancers at a young age.
His research extended to environmental and lifestyle risk factors for cancer. For many years, Dr. Fraumeni directed the preeminent cancer epidemiology program at the National Cancer Institute in Bethesda, Maryland. This leadership enabled advancements that have since identified over 120 genes linked to cancer predisposition.
Dr. Fraumeni's early work began in the 1960s, predating advanced molecular technology. The study of four families revealed a hereditary link to cancer, later identified as Li-Fraumeni syndrome. In 1990, a significant breakthrough traced the syndrome to a mutation in the TP53 gene, a first for inherited cancer predisposition.
Beyond genetics, Dr. Fraumeni mapped cancer mortality across the U.S. in the 1970s, creating the U.S. Atlas of Cancer Mortality. These maps highlighted cancer clusters linked to environmental exposures like arsenic and asbestos, leading to policy changes and preventing numerous cancer cases and deaths.
